Cargando…
New hope for devastating neurodegenerative disease
This scientific commentary refers to ‘Insulin resistance and exendin-4 treatment for multiple system atrophy’, by Bassil et al., (doi:10.1093/brain/awx044).
Autores principales: | Stayte, Sandy, Vissel, Bryce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405336/ https://www.ncbi.nlm.nih.gov/pubmed/29050369 http://dx.doi.org/10.1093/brain/awx064 |
Ejemplares similares
-
Advances in non-dopaminergic treatments for Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014) -
Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014) -
Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson’s Disease
por: Stayte, Sandy, et al.
Publicado: (2015) -
Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
por: Rentsch, Peggy, et al.
Publicado: (2019) -
Parafascicular Thalamic and Orbitofrontal Cortical Inputs to Striatum Represent States for Goal-Directed Action Selection
por: Stayte, Sandy, et al.
Publicado: (2021)